
Public drug program spending in Canada by top drug classes 2018
This statistic shows the top 10 drug classes in Canada based on share of total public drug program expenditures in 2018. In that year, 2.2 percent of total drug program spending was dedicated to HMG-CoA reductase inhibitors (statins) which are often used for treating high cholesterol.